Rankings
▼
Calendar
ARGX (argenx SE) Stock Financials & Earnings | Market Cap Arena
ARGX
argenx SE
Mkt Cap
$46B
Healthcare
·
Biotechnology
·
🇳🇱 Netherlands
·
NASDAQ
Revenue (TTM)
$3.7B
Net Income (TTM)
$1.4B
EPS (TTM)
$22.54
Free Cash Flow (TTM)
$213M
Gross Margin
75.0%
Op. Margin
12.9%
Net Margin
37.5%
FCF Margin
5.8%
P/S Ratio (TTM)
12.6x
P/E Ratio (TTM)
33.6x
YoY Rev Growth
+53.0%
Employees
—
Earnings Reports
▶
Q2 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q2 22
$111M
-$169M
-$379M
Q4 22
$303M
-$78M
-$302M
Q1 23
-$258M
$550M
$43M
Q2 23
$468M
$107M
-$189M
Q3 23
$330M
$294M
-$81M
Q4 23
$758M
$184M
-$219M
Q1 24
$401M
$358M
-$93M
Q2 24
$902M
$1.3B
-$139M
Q3 24
$573M
$514M
$14M
Q4 24
$1.3B
$681M
$117M
Q1 25
$791M
$710M
$139M
Q2 25
$948M
$837M
$201M
marketcaparena.com
Revenue Breakdown
ARGX
argenx SE
Revenue Breakdown
Q2 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q2 22
79.3x
—
Q4 22
53.5x
—
Q1 23
252.5x
—
Q2 23
73.7x
—
Q3 23
54.6x
—
Q4 23
35.5x
—
Q1 24
23.5x
—
Q2 24
19.3x
—
Q3 24
17.5x
—
Q4 24
14.3x
53.4x
Q1 25
12.7x
42.1x
Q2 25
12.6x
33.6x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q4 19
-$94M
-$95M
Q2 20
-$133M
-$134M
Q4 20
-$204M
-$204M
Q2 21
-$190M
-$192M
Q4 21
-$335M
-$336M
Q2 22
-$472M
-$472M
Q4 22
-$344M
-$345M
Q2 23
-$258M
-$262M
Q4 23
-$135M
-$135M
Q2 24
-$125M
-$125M
Q4 24
$42M
$41M
Q2 25
$438M
$433M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q4 19
$926K
Q2 20
$659K
Q4 20
$268K
Q2 21
$2M
Q4 21
$1M
Q2 22
$175K
Q4 22
$611K
Q2 23
$443K
Q4 23
$333K
Q2 24
$811K
Q4 24
$990K
Q2 25
$5M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q2 22
+264.8%
+115.1%
Q4 22
+1237.9%
+160.7%
Q1 23
-161.4%
-188.4%
Q2 23
+1698.1%
+57.9%
Q3 23
+196.2%
-16.3%
Q4 23
+150.1%
+61.6%
Q1 24
+255.4%
+264.4%
Q2 24
+92.6%
+58.5%
Q3 24
+73.8%
+36.2%
Q4 24
+77.7%
+25.8%
Q1 25
+97.2%
+31.8%
Q2 25
+5.1%
-28.2%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q4 19
$31M
98.5%
Q2 20
$39M
129.2%
Q4 20
$47M
207.8%
Q2 21
$92M
21.9%
Q4 21
$87M
335.3%
Q2 22
$77M
68.8%
Q4 22
$75M
24.8%
Q2 23
$94M
20.0%
Q4 23
$131M
17.3%
Q2 24
$103M
11.4%
Q4 24
$128M
9.5%
Q2 25
$0
0.0%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
SG&A
Quarter
R&D
G&A
S&M
SG&A
Q2 22
$276M
—
—
$218M
Q4 22
$384M
—
—
$227M
Q1 23
—
$507M
$202M
—
Q2 23
$331M
—
—
$285M
Q3 23
$192M
—
—
$192M
Q4 23
$397M
$199M
$202M
—
Q1 24
$225M
—
—
$236M
Q2 24
$447M
$341M
$150M
—
Q3 24
$236M
—
—
$278M
Q4 24
$297M
$257M
$307M
—
Q1 25
$309M
—
—
$276M
Q2 25
$328M
$423M
$178M
—
marketcaparena.com
Revenue by Geography
Emea
Japan
United States
Quarter
Emea
Japan
United States
Q2 23
$23M
$24M
$441M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q2 21
$1.6B
$1.1B
$2.7B
Q4 21
$1.3B
$1.0B
$2.3B
Q2 22
$1.4B
$1.2B
$2.6B
Q4 22
$801M
$1.4B
$2.2B
Q2 23
$1.1B
$886M
$2.0B
Q4 23
$2.0B
$1.1B
$3.2B
Q2 24
$1.4B
$1.7B
$3.1B
Q4 24
$1.5B
$1.9B
$3.4B
Q2 25
$2.1B
$1.8B
$3.9B
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q2 22
53M
+3.8%
Q4 22
55M
+3.5%
Q1 23
56M
+0.7%
Q2 23
56M
+0.0%
Q3 23
58M
+4.4%
Q4 23
58M
+0.3%
Q1 24
59M
+1.8%
Q2 24
59M
+0.2%
Q3 24
66M
+10.7%
Q4 24
71M
+7.9%
Q1 25
66M
-7.5%
Q2 25
66M
-0.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 21
$765K
650
FY 22
$487K
843
FY 23
$1M
1K
FY 24
$1M
2K
marketcaparena.com